White Diamond’s new findings show why AXDX’s Pheno system is unlikely to realize the revenue the street is expecting. The issues we have found have been missed by most.
Accelerate Diagnostics (AXDX) is a rapid diagnostic company that relies on one product, the Pheno system, utilizing PhenoTest diagnostic panels. The stock has been up over 70% in the year which we believe has created a very juicy shorting opportunity. What amazes us is that despite the continuous rise in stock price, the company has continued to miss earnings and other important metrics over